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Summary
What is already known on this topic?
Racial/ethnic minority women are disproportionately affected by type 2
diabetes. Among racial/ethnic minority women, non-Hispanic black wo-
men are at lowest risk for gestational diabetes mellitus (GDM) but highest
risk for conversion to type 2 diabetes after GDM.
What is added by this report?
In this nationally representative population of US women with a history of
GDM, non-Hispanic black women, compared with other racial/ethnic
groups, were most likely to report receiving diabetes screening services in
the past 3 years. However, non-Hispanic black and Hispanic women had
higher HbA1c levels and were more likely to have measured HbA1c values
in the prediabetes or diabetes range.
What are the implications for public health practice?
Screening for and prompt diagnosis of type 2 diabetes after GDM is critic-
al in reducing complications. Differential receipt of follow-up services by ra-
cial/ethnic minority women may exacerbate disparities in the prevalence
of type 2 diabetes.
Abstract
Introduction
Gestational diabetes mellitus (GDM) is the most common com-
plication of pregnancy and is associated with an increased risk for
type 2 diabetes. Racial/ethnic minority populations are at a higher
risk than non-Hispanic white populations of developing type 2 dia-
betes after GDM. The aim of this study was to describe racial/eth-
nic differences in hyperglycemia and receipt of screening services
in a nationally representative sample of women with a history of
GDM.
Methods
Our sample included 765 women from the US National Health and
Nutrition  Examination  Survey  (2007–2016)  with  a  history  of
GDM. We used logistic, multinomial, linear, and proportional haz-
ards regression to evaluate racial/ethnic differences in develop-
ment of diabetes after GDM, hyperglycemia (measured by HbA1c),
and receipt of diabetes screening services.
Results
Non-Hispanic black women had 63% higher risk and Hispanic
women and “other” racial/ethnic women had more than double the
risk  for  diabetes  compared  with  non-Hispanic  white  women.
Among women with a GDM history who did not receive a dia-
gnosis of diabetes by the time of the study examination, both non-
Hispanic black women and Hispanic women were more likely
than non-Hispanic white women to be in the prediabetes or dia-
betes range (measured HbA1c  ≥5.7%). However, non-Hispanic
black women had 2.07 (95% confidence interval, 1.29–3.81) times
the odds of being screened for diabetes compared with non-His-
panic white women (P = .02).
Conclusion
Delays in identification of hyperglycemia and diagnosis of dia-
betes in racial/ethnic minority women may reflect differential de-
livery  of  guideline-based  care  or  poor  follow-up of  abnormal
screening test results.
Introduction
Gestational diabetes mellitus (GDM) affects 2% to 14% of all
pregnancies in the United States and confers a significant and
lifelong health challenge for both mother and infant, including an
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increased risk for type 2 diabetes (1–3). Approximately 60% of
women with GDM will develop diabetes within 10 years after de-
livery, and GDM history is associated with a 7-fold increased life-
time risk for diabetes (2,3). This population comprises a high-risk
group that should be targeted for enhanced diabetes screening.
Clinical guidelines recommend postpartum glucose screening 4 to
12 weeks after a GDM pregnancy, yet an inadequate proportion of
women with GDM receive these screenings (4). Estimates for re-
ceipt of the postpartum glucose screening vary between one-third
and three-quarters of postpartum women, depending on the popu-
lation, with low-income and racial/ethnic minority populations less
likely to meet guideline-based screening recommendations (5–7).
For people who do not receive a diagnosis of diabetes at the post-
partum visit (90%–95% of all those screened), clinical guidelines
recommend  enhanced  rescreening  (8).  For  people  with  post-
partum glucose screening results in the normoglycemic range, re-
screening is recommended at least every 3 years; people with val-
ues in the prediabetes range should be rescreened annually. This
repeated screening approach improves timely identification of pre-
diabetes or type 2 diabetes and increases success of efforts to pre-
vent or delay progression to type 2 diabetes.
The likelihood of developing type 2 diabetes after GDM differs
across racial/ethnic groups. For example, black women with GDM
are nearly 10 times as likely as women of all racial/ethnic groups
without GDM to develop type 2 diabetes (9). We hypothesized
that these observed disparities may partially be driven by differen-
tial receipt of screening services. Thus, the aim of this study was
to describe racial/ethnic differences in the development of type 2
diabetes, levels of glycated hemoglobin (HbA1c) (a measure of hy-
perglycemia), and receipt of screening services based on clinical
guidelines in a nationally representative sample of women with a
history of GDM.
Methods
We analyzed data from the National Health and Nutrition Examin-
ation Survey (NHANES) for 2007–2016. NHANES is a cross-sec-
tional, nationally representative survey of the US civilian noninsti-
tutionalized  population  conducted  by  the  National  Center  for
Health Statistics (10). This study was a secondary data analysis
that included 765 NHANES participants with a history of GDM
who self-identified as female, were aged 18 years or older, and
had self-reported information on current diabetes status at the time
of their NHANES examination. A human subjects review board
approved data collection procedures, and written informed con-
sent was obtained from all study participants (11).
Measures
Race/ethnicity and other demographic characteristics, GDM and
diabetes diagnoses, current use of insulin, reproductive history,
health behaviors, health history, family history, health insurance
status, health care access, and receipt of diabetes screening tests
were determined by self-report. We categorized race/ethnicity as
non-Hispanic white, non-Hispanic black, Hispanic, and “other.”
The “other” category comprises women in all other racial/ethnic
categories indicated in NHANES as well as women who indicated
multiple races/ethnicities. Income-to-poverty ratio was quantified
by dividing family income by the poverty threshold determined by
the US Department of Health and Human Services, specific to
family size; a poverty-income ratio below 1 indicates that the fam-
ily is below the poverty threshold. GDM history was defined as
self-reported diagnosis of diabetes for the first time during preg-
nancy; age at GDM diagnosis was also reported. Development of
type 2 diabetes after GDM was defined at the time of NHANES
examination as self-reported diagnosis of diabetes by a health care
provider (not including diabetes diagnosed during pregnancy) or
use of insulin; age at diabetes diagnosis was also reported by parti-
cipants. For women who did not develop diabetes after GDM, re-
ceipt of screening for diabetes during the previous 3 years was de-
termined by using the following question: “Have you had a blood
test for high blood sugar or diabetes within the past three years?”
Blood pressure, body mass index (BMI), waist circumference, and
lipids  were  directly  measured  by  using  standard  methods  de-
scribed previously (12). HbA1c was measured by using high-per-
formance liquid chromatography, standardized to the Diabetes
Control and Complications Trial assay (13).
Statistical analysis
We assessed differences in participant characteristics across racial/
ethnic groups by analysis of variance or χ2 test as appropriate. For
analyses, we defined undiagnosed diabetes as measured HbA1c
equal to or greater than 6.5% in the absence of a diagnosis of dia-
betes or use of insulin and prediabetes as HbA1c  from 5.7% to
6.4% in the absence of a diagnosis of diabetes or use of insulin.
We used multinomial logistic regression to evaluate the associ-
ation of race/ethnicity with undiagnosed diabetes (HbA1c ≥6.5%),
prediabetes (HbA1c 5.7%–6.4%), and no diabetes (HbA1c <5.7%)
at the time of NHANES examination among women with no dia-
betes (as defined by self-report diagnosis or use of insulin). We
evaluated associations of race/ethnicity with HbA1c as a continu-
ous outcome at the time of NHANES examination by using mul-
tivariable linear regression, stratified by women with and without
diabetes.
Cox proportional hazards regression was used to assess the associ-
ation of race/ethnicity with development of type 2 diabetes after
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GDM, using the difference between age at GDM diagnosis and
age at diabetes diagnosis after pregnancy (if applicable) as the
time to event; for participants who did not develop diabetes, we
calculated follow-up time as the difference between GDM dia-
gnosis and current age. Women were excluded if they reported an
age at type 2 diabetes diagnosis that was before the age at GDM
diagnosis or had missing information on age at type 2 diabetes dia-
gnosis or GDM diagnosis. The proportional hazards assumption
was assessed, and it was not violated.
Associations of race/ethnicity, socioeconomic status, and access to
health care with receipt of screening services were modeled by us-
ing logistic regression among women without diabetes (based on
self-report or insulin use information). Analyses incorporated the
NHANES sample weights and accounted for the complex sample
survey design by using standard methods (12). We used the Taylor
series linearization method for variance estimation. Analyses were
performed in Stata Statistical Software release 14.2 (StataCorp
LLC).
Results
Among 765 women with a history of GDM, 24.4% developed type
2 diabetes after GDM (weighted percentage). This did vary, al-
though not significantly, across race/ethnicity and was highest
among non-Hispanic black women (30.8%) and Hispanic women
(31.0%) (Table 1). Approximately one-fifth (22.1%) of non-His-
panic white women and 18.3% of women of “other” race/ethni-
city  developed type  2  diabetes  after  GDM (Table  1).  Women
differed significantly across racial/ethnic groups at the time of
NHANES examination in the number of past pregnancies (P <
.001), BMI (P <.001), hypertension prevalence (P = .015), and
waist circumference (P <.001) (Table 1). Hispanic women were
most likely to report not having health insurance (34.8% of His-
panic women, compared with 12.5% of non-Hispanic white wo-
men) (P < .001), and 20.0% of Hispanic women reported not hav-
ing access to a routine location for health care (P = .009 across ra-
cial/ethnic groups).
Associations of race/ethnicity with HbA1c
In a fully adjusted model (Table 2), non-Hispanic black women,
Hispanic women, and women in “other” racial/ethnic groups had
significantly higher HbA1c levels than did non-Hispanic white wo-
men. Among women with diabetes (by self-report or insulin use),
non-Hispanic black and Hispanic women had 1.32% (P = .002)
and 1.31% (P < .001) higher HbA1c, respectively, compared with
non-Hispanic white women; the “other” racial/ethnic group did
not differ significantly from the non-Hispanic white group (P =
.57). Among women with no diabetes, non-Hispanic black and
Hispanic women had 0.34% higher HbA1c (P = .004 among non-
Hispanic black women; P = .001 among Hispanic women), where-
as the “other” racial/ethnic group had a 0.14% higher HbA1c (P =
.03), compared with non-Hispanic white women. In fully adjusted
models (Table 2), the relative risk ratio for prediabetes was 3.4-
fold higher (95% confidence interval [CI], 1.60–7.04); P = .002)
and for HbA1c ≥6.5% was 5.2-fold higher (95% CI, 1.39–19.70); P
= .02) among non-Hispanic black women than among non-Hispan-
ic white women. Among Hispanic women, the relative risk ratio
for prediabetes was 2.2-fold higher (95% CI, 1.17–4.17; P = .02)
and for HbA1c ≥6.5% was 6.7-fold higher (95% CI, 2.51–17.98; P
<.001) than among non-Hispanic white women.
Associations of race/ethnicity with development of
type 2 diabetes after GDM
Among the 765 women with a history of GDM, 6 were missing in-
formation on age at diabetes diagnosis and were excluded from
analysis. In fully adjusted models, non-Hispanic black women had
a 63% higher risk (95% CI, 1.11–2.39; P = .01), Hispanic women
more than double the risk (hazard ratio = 2.22; 95% CI, 1.47–3.35;
P < .001), and “other” racial/ethnic women approximately double
the risk (hazard ratio = 2.08; 95% CI, 1.01–4.28; P = .047) of de-
veloping type 2 diabetes following GDM compared with non-His-
panic whites (Table 3).
Receipt of screening among women without
diabetes
Among women without diabetes (defined by self-report or insulin
use) at the NHANES examination, 67.1% reported having had a
diabetes screening test at least once in the past 3 years. By race/
ethnicity, this percentage was 67.1% among non-Hispanic white
women, 77.3% among non-Hispanic black women, 59.2% among
Hispanic women, and 72.6% among women in “other” racial/eth-
nic groups (Table 1). In adjusted models, non-Hispanic black wo-
men had 2.07 times the odds of being screened for diabetes com-
pared with non-Hispanic white women (95% CI, 1.29–3.81; P =
.02)  (Table  4).  Women with  a  higher  income-to-poverty  ratio
(odds ratio [OR] per 1-unit increment = 1.27; 95% CI, 1.08–1.49;
P = .005) were more likely to have been screened, and women
who reported no access to a routine place for health care (com-
pared with those with access to ≥1 location for regular health care)
had 0.44 times the odds of being screened (95% CI, 0.22–0.90; P
=.02) (Figure). Other potential factors were considered but were
removed from the final model because of no observed association;
these factors were education, marital status, current age, and health
insurance status. Sensitivity analyses adjusting for clinical dia-
betes risk factors only slightly attenuated the findings on race/eth-
nicity.
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Figure. Racial/ethnic differences in having been screened for diabetes at least
once in the past 3 years, US women without diabetes (n = 496). Odds ratios
were adjusted for all other variables in the figure. Error bars indicate 95%
confidence intervals.
Discussion
In our study, non-Hispanic black and Hispanic women were at
higher risk for developing type 2 diabetes after GDM compared
with  non-Hispanic  white  women,  and  they  had  higher  HbA1c
levels. Among all racial/ethnic groups examined, non-Hispanic
black women were most likely to have measured HbA1c values in
the prediabetes (HbA1c 5.7%–6.4%) and diabetes range (HbA1c ≥
6.5% in the absence of a diagnosis of diabetes). Both groups had
higher rates of prediabetes and diabetes compared with non-His-
panic white women. Non-Hispanic black and Hispanic women had
significantly higher mean HbA1c levels, regardless of current dia-
gnosed diabetes status.
Racial/ethnic disparities in risk for type 2 diabetes after GDM are
well documented. Although non-Hispanic white and black women
are at similar risk for GDM, black women have more than 2 times
higher risk for developing type 2 diabetes after GDM compared
with non-Hispanic white women (9). Heterogeneity in the burden
of GDM risk and consequences within these subgroups cannot be
fully explained by biological factors and traditional diabetes risk
factors, and it is likely strongly influenced by social determinants
and differential patterns of clinical practice (14). In our study, ra-
cial/ethnic differences in risk for diagnosed type 2 diabetes after
GDM persisted even after adjustment for traditional diabetes risk
factors such as age, education level, and BMI, and health insur-
ance status. These findings demonstrate a gap in our understand-
ing of individual and clinical practice factors — beyond tradition-
al diabetes risk factors — influencing development of type 2 dia-
betes among racial/ethnic minority women.
The proportion of women reporting receipt of a diabetes screen-
ing test varied by race/ethnicity in the US population of women
with a GDM history, despite the clinical recommendation that all
women with GDM history be screened every 1 to 3 years. The
finding that non-Hispanic black women without current diabetes,
but with a history of GDM, were more likely to be screened for
diabetes is consistent with their more adverse diabetes risk profile,
including higher mean blood pressure, BMI, and prevalence of
family history of diabetes. Despite being screened and demonstrat-
ing a higher prevalence of hyperglycemia, they were less likely to
receive a diagnosis of diabetes. In unadjusted (crude) models, non-
Hispanic black women had higher odds and Hispanic women had
lower odds of being screened compared with non-Hispanic white
women. This association became nonsignificant after adjustment
for sociodemographic, clinical, and health care access factors for
Hispanic women, but the association became stronger for non-His-
panic black women.
The lower percentage of  Hispanic women who reported being
screened for diabetes is consistent with the observed lower per-
centage who had current health insurance and lower percentage re-
porting access to a routine location to obtain health care compared
with non-Hispanic white women. More than 30% of Hispanic wo-
men with a GDM history were subsequently diagnosed with dia-
betes, higher than the percentage among non-Hispanic white wo-
men and similar to the percentage among non-Hispanic black wo-
men. However, among women that had not been diagnosed with
diabetes, Hispanic women had lower odds of being screened for
diabetes in the previous 3 years compared with all other racial/eth-
nic groups in unadjusted models. The association of race/ethnicity
with receipt of screening became nonsignificant for Hispanic wo-
men after adjusting for measures of household income and access
to a routine health care location. This finding suggests that access
to screening services may play an important role in the observed
lower likelihood of diabetes screening in this population.
Our findings also support research that non-Hispanic black wo-
men, in particular, are more likely to have undiagnosed predia-
betes  or  diabetes  and have  a  higher  prevalence  of  suboptimal
HbA1c (15–19). These findings might partially reflect delays in
early diagnosis of diabetes that may result from differential deliv-
ery of guideline-based care and/or follow-up of abnormal screen-
ing test results. Non-Hispanic black women may be screened more
frequently because of perceived increased risk or higher preval-
ence of known diabetes risk factors, but evidence suggests that we
are missing opportunities  for  early identification of  hypergly-
cemia in this population. Health care providers play an important
role in the diagnosis and treatment of diabetes for at-risk popula-
tions. Timely coordinated medical care is crucial because racial/
ethnic minority patients are often diagnosed at later stages of dis-
ease than are other racial/ethnic groups (20). Studies are needed to
further examine racial/ethnic differences in diagnosis and treat-
ment of diabetes, as well as the underlying factors that may limit
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adherence to guideline-based care among racial/ethnic minority
populations.
Although NHANES is  a  cross-sectional  survey,  it  collects  de-
tailed information about pregnancy history and timing of diabetes
diagnoses, allowing for estimation of diabetes risk after GDM.
Additionally, non-Hispanic black and Hispanic women were over-
sampled to provide a large study population to evaluate racial/eth-
nic differences; Asian women were not oversampled in most sur-
vey years and, therefore, we were not able to look at this subpopu-
lation separately. Finally, diabetes diagnosis information was col-
lected via self-report; potential misclassification cannot be ruled
out. However, the study is strengthened by inclusion of a nation-
ally representative sample of US women with a GDM history and
extensive information about their social and family history, health
behaviors, health status and history, and several indicators related
to access to health services.
Screening and diagnosis of GDM is critical in reducing complica-
tions in women and their infants, as well as preventing onset of
type 2 diabetes. Differential receipt of follow-up services by ra-
cial/ethnic minority women may exacerbate observed disparities in
the burden of type 2 diabetes. Our study showed racial/ethnic dis-
parities in diabetes diagnosis, receipt of diabetes screening tests,
and HbA1c levels. Additional investigation to identify underlying
factors contributing to this observed disparity will be particularly
important to inform recommendations to ensure more equitable
delivery of quality care across populations.
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Tables
Table 1. Characteristics of Women Aged ≥18 Years With a History of Gestational Diabetes Mellitus (N = 765), National Health and Nutrition Examination Survey
(NHANES), 2007–2016a
Characteristic
Non-Hispanic White
(n = 267)
Non-Hispanic Black
(n = 138)
Hispanic
(n = 266)
Otherb
(n = 94) P Valuec
Age, y 46.5 (0.9) 44.4 (1.0) 41.8 (0.7) 42.6 (1.6) <.001
No. of live births 2.4 (0.1) 2.7 (0.1) 3.0 (0.1) 2.0 (0.2) <.001
No. of pregnancies 3.3 (0.1) 3.9 (0.2) 3.9 (0.1) 3.0 (0.2) <.001
Body mass index, kg/m2 31.2 (0.5) 32.8 (0.9) 31.7 (0.5) 28.1 (1.3) <.001
Waist circumference, cm 102.0 (1.1) 104.4 (1.9) 101.5 (1.1) 93.8 (2.5) .02
Current smoker, % 19.3 19.6 10.8 9.1 <.001
Systolic blood pressure, mm Hg 116.5 (1.1) 123.9 (1.7) 120.7 (1.3) 119.5 (4.4) .23
Diastolic blood pressure, mm Hg 70.9 (0.7) 71.9 (1.1) 68.9 (1.0) 69.8 (1.6) .02
Hypertension, % 37.5 56.1 34.1 34.5 .02
Total cholesterol, mg/dL 198.8 (3.1) 186.7 (3.6) 200.4 (4.2) 198.8 (10.8) .52
High-density lipoprotein cholesterol,
mg/dL
54.3 (1.1) 54.0 (1.5) 52.2 (1.4) 53.4 (2.2) .40
Family history of diabetes, % 58.2 69.8 59.7 61.7 .72
Developed type 2 diabetes after GDM, % 22.1 30.8 31.0 18.3 .01
HbA1c category, %
No current diabetes, <5.7% 53.2 32.5 41.1 53.2
.11
No current diabetes, 5.7%–6.4% 20.2 28.5 21.2 26.5
No current diabetes, ≥6.5% 4.5 8.2 6.7 2.0
Current diabetes, <7.0% 13.7 13.6 12.4 13.0
Current diabetes, ≥7.0% 8.4 17.2 18.6 5.4
Had diabetes screening in past 3 yearsd 67.1 77.3 59.2 72.6 .11
No health insurance, % 12.5 14.6 34.8 17.0 <.001
No routine health care location, % 9.2 3.4 20.0 12.2 .009
Education, %
<High school diploma 12.2 16.6 45.3 5.3
<.001
High school diploma or equivalent 20.0 19.4 19.3 15.4
Some college 39.4 40.6 26.7 27.9
College graduate or higher 28.3 23.4 8.8 51.4
Income-to-poverty ratioe 3.1 (0.1) 2.3 (0.2) 1.8 (0.1) 3.4 (0.2) <.001
Abbreviations: HbA1c, glycated hemoglobin A1c.a All values are weighted mean (standard error) for continuous variables and weighted percentage for categorical or binary variables, unless otherwise indicated.
Unweighted sample size ranged from 630–765 because of missing data.
b Comprises women in all other racial/ethnic categories indicated in NHANES as well as women who indicated multiple race/ethnicities.
c Analysis of variance used to determine P values for continuous values and χ2 tests for categorical values.
d Calculated only among those without diabetes at the time of NHANES data collection (unweighted n = 534).
e Income-to-poverty ratio was quantified by dividing family income by the poverty threshold determined by the US Department of Health and Human Services, spe-
cific to family size; a poverty-income ratio below 1 indicates that the family is below the poverty threshold.
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Table 2. Racial/Ethnic Differences Among Women Aged ≥18 Years in Association With HbA1c, National Health and Nutrition Examination Survey (NHANES),
2007–2016
Characteristic
RRR (95% CI) [P] HbA1c, β (95% CI) [P]
HbA1c 5.7%–6.4%
a
(Unweighted n = 534)
HbA1c ≥6.5%
a
(Unweighted n = 534)
No Diabetes
(Unweighted n = 534)
Diabetes
(Unweighted n = 231)
Model 1: Unadjusted
Non-Hispanic white 1.00 [Reference] 1.00 [Reference] 1.00 [Reference] 1.00 [Reference]
Non-Hispanic black 2.31 (1.30 to 4.13) [.005] 2.98 (1.01 to 8.79) [.05] 0.31 (0.07 to 0.56) [.01] 1.12 (0.19 to 2.05) [.02]
Hispanic 1.36 (0.82 to 2.26) [.22] 1.94 (0.80 to 4.68) [.14] 0.24 (0.05 to 0.43) [.01] 0.90 (0.26 to 1.54) [.006]
Other 1.32 (0.49 to 3.54) [.58] 0.44 (0.11 to 1.86) [.26] 0.06 (−0.10 to 0.21) [.45] −0.30 (−0.83 to 0.23) [.26]
Model 2: Adjusted for age, education, marital status, and health insurance status
Non-Hispanic white 1.00 [Reference] 1.00 [Reference] 1.00 [Reference] 1.00 [Reference]
Non-Hispanic black 3.46 (1.77 to 6.78) [<.001] 4.94 (1.53 to 15.96) [.008] 0.40 (0.15 to 0.65) [.002] 1.30 (0.46 to 2.14) [.003]
Hispanic 1.98 (1.07 to 3.67) [.03] 3.49 (1.57 to 8.04) [.004] 0.34 (0.14 to 0.54) [.001] 1.17 (0.55 to 1.78) [<.001]
Other 1.97 (0.70 to 5.50) [.19] 0.61 (0.12 to 3.23) [.56] 0.14 (−0.01 to 0.29) [.06] −0.29 (−0.84 to 0.27) [.31]
Model 3: Model 2 + body mass index, waist circumference, hypertension status, and high-density lipoprotein cholesterol
Non-Hispanic white 1.00 [Reference] 1.00 [Reference] 1.00 [Reference] 1.00 [Reference]
Non-Hispanic black 3.35 (1.60 to 7.04) [.002] 5.24 (1.39 to 19.70) [.02] 0.34 (0.11 to 0.57) [.004] 1.32 (0.48 to 2.15) [.002]
Hispanic 2.20 (1.17 to 4.17) [.02] 6.72 (2.51 to 17.98) [<.001] 0.34 (0.15 to 0.53) [.001] 1.31 (0.71 to 1.91); [<.001]
Other 2.09 (0.83 to 5.30) [.12] 0.96 (0.08 to 11.18) [.97] 0.14 (0.01 to 0.27) [.03] −0.15 (−0.67 to 0.37) [.57]
Abbreviations: CI, confidence interval; HbA1c, glycated hemoglobin A1c; RRR, relative risk ratio.a Among women aged ≥18 years who had complete information on covariates and who did not self-report a diagnosis of diabetes by a health care provider or in-
sulin use at the time of the NHANES examination. Multinomial regression models were used to assess undiagnosed diabetes (HbA1c ≥ 6.5%), prediabetes (HbA1c,
5.7%–6.4%), and no diabetes (HbA1c < 5.7%). No diabetes is reference group (or base outcome).
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Table 3. Racial/Ethnic Differences in the Development of Type 2 Diabetes Among Women Aged ≥18 Years With a History of Gestational Diabetes Mellitus (N =
759), National Health and Nutrition Examination Survey, 2007–2016a
Model Non-Hispanic White
Hazard Ratio (95% Confidence Interval) [P Value]
Non-Hispanic Black Hispanic Other
Model 1b 1.00 [Reference] 1.95 (1.32–2.88) [.001] 2.17 (1.44–3.25) [<.001] 1.18 (0.56–2.51) [.66]
Model 2c 1.00 [Reference] 1.71 (1.13–2.58) [.01] 1.68 (1.09–2.60) [.02] 1.57 (0.80–3.09) [.19]
Model 3d 1.00 [Reference] 1.63 (1.11–2.39) [.01] 2.22 (1.47–3.35) [<.001] 2.08 (1.01–4.28) [.047]
a Of 765 women aged ≥18 years with a history of gestational diabetes mellitus, 6 did not have data on age at diabetes diagnosis.
b Unadjusted.
c Adjusted for age, education, marital status, and health insurance status.
d Model 2 + body mass index, waist circumference, hypertension status, and high-density lipoprotein cholesterol.
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Table 4. Racial/Ethnic Differences in Screening for Diabetes Among Women Aged ≥18 Years Without Current Diabetes (n = 496), National Health and Nutrition Ex-
amination Survey, 2007–2016a
Model Non-Hispanic White
Odds Ratio (95% Confidence Interval) [P Value]
Non-Hispanic Black Hispanic Other
Unadjusted 1.00 [Reference] 1.89 (0.98–3.22) [.06] 0.66 (0.40–1.07) [.09] 1.16 (0.55–2.48) [.69]
+ Income-to-poverty ratiob 1.00 [Reference] 2.22 (1.22–4.03) [.009] 0.91 (0.53–1.56) [.73] 1.11 (0.52–2.35) [.78]
+ Routine health care location 1.00 [Reference] 2.07 (1.29–3.81) [.02] 1.01 (0.58–1.78) [.96] 1.10 (0.51–2.38) [.24]
a Among 534 women aged ≥18 years with no diabetes, 38 were missing information on income-to-poverty ratio and routine health care location.
b Income-to-poverty ratio was quantified by dividing family income by the poverty threshold determined by the US Department of Health and Human Services, spe-
cific to family size; a poverty-income ratio below 1 indicates that the family is below the poverty threshold.
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